MG-3C
Product Specifications
Target
STAT, EGFR, MMP, Apoptosis
Related Pathways
Stem Cells, Angiogenesis, Tyrosine Kinase/Adaptors, Apoptosis, Proteases/Proteasome, JAK/STAT signaling
Bioactivity
MG-3C is a potent inhibitor of matrix metalloproteinase 9 (MMP-9) . It selectively targets and kills non-small cell lung cancer (NSCLC) cells harboring the EGFR T790M mutation. By blocking the EGFR/STAT3 signaling pathway, MG-3C induces cell cycle arrest at the G2/M phase, inhibits growth, and triggers apoptosis. This compound shows potential for lung cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1237678 0.1 mg
Fletikumab (IL20) - Research Grade Biosimilar Antibody
Sign In for Pricing
View Details TL314895V 500 µL Each
AGL Human shRNA Lentiviral Particle (Locus ID 178)
Sign In for Pricing
View Details